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Because interferon-g, interleukin-4, and interleukin-5
have been identi®ed at the mRNA and protein levels
in the lesional skin of patients with atopic dermatitis,
we investigated the roles played by granulocytes as
effector cells in allergic in¯ammation by using two
unique murine skin models. In vitro generated Th1
and Th2 cells from naõÈve splenocytes of antiovalbu-
min T cell receptor transgenic BALB/C mice were
adoptively transferred with ovalbumin into the ear
pinnae or air-pouches produced in the back skin of
naõÈve, nontransgenic BALB/C mice. The injection
of Th1 cells with ovalbumin induced delayed type
ear swelling that peaked at 48 h, whereas that of
Th2 resulted in ear swelling that peaked at a much
earlier time, 24 h. Histologic study of the swollen
ear skin and granulocytes recruited into the air-
pouch demonstrated that, although the Th1-induced
in¯ammation caused a neutrophil-predominant
in®ltrate with few eosinophils, larger numbers of
eosinophils accumulated in the Th2-induced in¯am-
mation. Using these murine models, we further
evaluated the effects of drugs used for the treatment
of atopic diseases. The results showed that FK506
administration could effectively reduce skin in¯am-
mation induced by either Th cells. Interestingly, the
neutrophil elastase inhibitor ONO-6818 ef®ciently
inhibited Th1-induced in¯ammation. In contrast, a
leukotriene receptor antagonist, ONO-1078, speci®c-
ally suppressed Th2-induced in¯ammation. We also
found that each ONO drug exerted direct in¯uence
on speci®ed granulocytes, as neither affected in vitro
production of relevant Th cytokines. Thus, we suc-
ceeded in developing animal skin in¯ammation
models in which we can evaluate the contribution of
protein antigen-speci®c Th1 or Th2 cells through the
action of granulocytic effector cells. Key words: eosi-
nophil/FK-506/neutrophil/Th1/Th2. J Invest Dermatol
117:236±243, 2001
T
here has been accumulating evidence indicating that
both Th1 and Th2 cytokines and their transcripts are
present in the lesional skin of patients with atopic
dermatitis (AD) (Tsicopoulos et al, 1994; Thepen et al,
1996; Werfel et al, 1996) as well as in an animal model
of AD (Spergel et al, 1999). Although the etiology of AD is not
fully understood, it is speculated that hypersensitivity to environ-
mental macromolecular protein antigens, e.g., food allergens and
Dermatophagoides, rather than to small molecular haptens plays an
important role in its pathomechanism. To investigate the mechan-
isms underlying the development of AD, we need an animal model
in which cutaneous in¯ammation is induced by Th1 or Th2 cells
reactive against these protein antigens.
In antigen-primed individuals, the initiation stage of delayed
type hypersensitivity (DTH) includes the activation of vascular
endothelial cells and the recruitment and activation of antigen-
speci®c T cells. The next effector stage of DTH involves the
synthesis of chemotactic and activating cytokines from antigen-
speci®c T cells. Subsequently, there occur the recruitment,
activation, and cytokine and reactive-oxygen-intermediate secre-
tion of effector cells such as granulocytes and macrophages and
an increase in vascular permeability (Askenase, 1992).
Adoptively transferred DTH that is induced by injecting primed
T cells and antigen into naõÈve mouse ear lobes represents the
latter effector stage of the DTH process (Bianchi et al, 1981;
Scovern and Kantor, 1982). It has been revealed that Th1
clones can induce footpad DTH (Cher and Mosmann, 1987;
Fong and Mosmann, 1989; MuÈller et al, 1993).
On the other hand, preactivated bulk-cultured and alloreactive
Th2 populations can induce interleukin 4 (IL-4) dependent footpad
DTH (MuÈller et al, 1993), although resting Th2 clones do not
induce DTH (Fong and Mosmann, 1989). With hematoxylin and
eosin (H&E) stained histologic sections, it has been shown that
neutrophils, but not eosinophils, accumulate in Th2 clone-
mediated in¯ammatory responses (MuÈller et al, 1993). These results
suggest that Th2 cells also have the potential to induce DTH-like
in¯ammation, partly through the action of granulocytic effector
cells.
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CD4+ T cells can develop into Th1 and Th2 cells, which are
characterized by the production of speci®c cytokines, i.e., Th1 cells
produce interferon-g (IFN-g), IL-2, and low levels of IL-10,
whereas Th2 cells produce IL-4, IL-5, IL-13, and high levels of IL-
10 (Mosmann and Coffman, 1989; Abbas et al, 1996). Naive T cells
can be induced to differentiate either into Th1 effector cells when
stimulated in the presence of IL-12 or into Th2 effector cells when
stimulated in the presence of IL-4 (Seder et al, 1992; Hsieh et al,
1993), although a number of other factors have been shown to
in¯uence the differentiation pathway of naõÈve CD4
+ T cells (Abbas
et al, 1996).
In this study, we freshly prepared ovalbumin (OVA) speci®c Th1
and Th2 cells by culturing naõÈve splenocytes obtained from anti-
OVA T cell receptor (TCR) transgenic (tg) mice in the presence of
appropriate cytokines and anticytokine antibody. Either Th1 or
Th2 cells were injected into murine ear lobes and air-pouches
developed on the mid-back of naõÈve mice to re-evaluate the roles of
effector cells played by granulocytes. Using these unique murine
skin models, we further investigated how therapeutic drugs used for
the treatment of AD and other atopic diseases would in¯uence the
ear swelling or granulocyte accumulation that is induced by these
CD4+ T cells.
MATERIALS AND METHODS
Animals Male BALB/C mice bred in our animal facility were used at
8±12 wk of age. BALB/C mice tg for TCR speci®c for OVA323-339
(anti-OVA TCR tg mice) were established as described previously (Sato
et al, 1994).
Reagents FK506 solution and ointment (0.1%) were gifts from
Fujisawa Pharmaceutical (Osaka, Japan). Drugs capable of inhibiting
granulocyte in®ltration, ONO-1078 and ONO-6818, were gifts from
Ono Pharmaceutical (Kyoto, Japan). FK506, ONO-1078, and ONO-
6818 were administered once intraperitoneally or orally just before the
adoptive transfer of Th cells. FK506 ointment was also applied topically
once on the ear lobes 1 h after injection of Th cells.
In vitro induction of Th1 and Th2 cells Spleen cells (3 3 107) from
unimmunized anti-OVA TCR tg mice were cultured in 12 ml of RPMI
1640 medium with OVA (100 mg per ml) together with IL-12 (1 ng per
ml; Genzyme, Cambridge, MA) for the induction Th1 cells or IL-4
(10 ng per ml; Genzyme) plus anti-IL-12 monoclonal antibody (0.1 mg
per ml; Genzyme) for that of Th2 cells for 3 d. The cells were cultured
in fresh medium without any cytokine or anticytokine antibody for
another 3 d. Graded doses of these cells were adoptively transferred
subcutaneously into the ear lobe without fractionation. From the in vitro
culture made without any cytokines or anticytokine antibody for another
3 d, viable lymphocytes were further enriched for CD4+ T cells by a
panning method as described previously (Sano et al, 1999). The CD4+
fraction was cultured with mitomycin C (Wako Chemical Industries,
Osaka, Japan) treated spleen cells of BALB/C mice as antigen-presenting
cells in the presence of OVA (100 mg per ml) in quadruplicate for 2 d in
96-well plates (Falcon, Lincoln Park, NJ). Culture supernatants were
assayed for IFN-g and IL-4.
Where indicated, ONO-6817 or ONO-1078 was added to Th
stimulation cultures at a ®nal concentration of 10 mg per ml [0.02%
dimethylsulfoxide (DMSO)] or 30 mg per ml (0.067% DMSO). DMSO
was included in the control cultures at the same concentrations.
Assays for IFN-g and IL-4 Supernatants obtained from 48 h cultures
of Th1 or Th2 cells developed from anti-OVA TCR tg mice were
assayed for cytokines by sandwich enzyme-linked immunosorbent assay
(ELISA), as described previously (Shirota et al, 2000). Puri®ed and
biotinylated monoclonal antibodies to IFN-g and IL-4 were purchased
from Pharmingen (San Diego, CA). Standard recombinant mouse IFN-g
and IL-4 were purchased from Genzyme.
Ear swelling assay Unless otherwise stated, 1 3 106 cells were
injected subcutaneously into the right ear lobes of naõÈve, non-tg male
BALB/C mice. A total of 30 or 50 ml of the cell suspension was injected
with a 1 ml syringe equipped with a 27 gauge 3 1/2 needle. The left
ear lobes were left untreated. The thickness of each ear lobe was
measured with a precision caliper (Mitsutoyo, Tokyo, Japan),
immediately before and at various time periods after injection. Ear
swelling was expressed as (thickness of the right ear after injection ±
thickness of the left ear) ± (thickness of the right ear before the injection
± thickness of the left ear) 3 0.01 mm. Results are shown as the mean
swelling 6 SD. Each experimental group comprised four to ®ve mice,
unless otherwise stated. In several experiments, determination of ear
thickness was performed in a blinded fashion. Student's t test was used
for statistical analysis.
Histology For histologic examination, 1 3 106 cells of Th1 or Th2
cells were adoptively transferred subcutaneously into the ears of naõÈve
BALB/C. Animals were sacri®ced 24 h or 48 h after injection. Ears were
®xed in 10% formalin for 2±3 d, and processed for paraf®n embedding.
Tissue sections (4 mm) were stained with H&E, mounted, and observed
in a blinded fashion. For staining of eosinophils, tissue sections were
stained with May±GruÈnwald±Giemsa.
Development of air-pouches on the mid-back of naõÈve BALB/c
mice Air-pouches were produced in the mid-back of naõÈve, non-tg
BALB/C mice by injecting 4 ml of air subcutaneously 6 d before the
adoptive transfer. One day before their injection, 2 ml of air were re-
injected to maintain the pouches. Two milliliters of Th cell suspensions
were adoptively transferred at a cell density of 1 3 106 cells per ml
phosphate-buffered saline (PBS) in the presence or absence of OVA. At
indicated time points after the adoptive transfer of Th cells, the back skin
was incised and opened without rupturing the air-pouches encapsulated
in a ®brous membrane. After an injection of 2 ml of PBS and shaking,
the contents of the cystic pouches were recovered on a Petri dish by
cutting the pouch membrane. Their total cell number was calculated and
differential lymphocyte cell count was carried out with smeared samples
stained with May±GruÈnwald±Giemsa.
RESULTS
Subcutaneous injection of OVA and in vitro prepared Th1 or
Th2 cells produced ear swelling that showed different time
courses Th1 and Th2 cells were prepared by a short-term culture
of splenic cells obtained from naõÈve anti-OVA TCR tg mice in the
presence of cytokines and anticytokine antibody as described in
Materials and Methods. Partially puri®ed CD4+ cells were incubated
with OVA (100 mg per ml) and mitomycin-C-treated spleen cells at
a density of 2 3 105 per well that were used as antigen-presenting
cells. Culture supernatants were assayed for IFN-g and IL-4. The
results showed that Th1 cells secreted IFN-g but little IL-4, whereas
Th2 cells secreted IL-4 but little IFN-g, as shown in Fig 1.
Cytokine secretions from Th1 or Th2 cells without OVA
stimulation or with irrelevant antigens (bovine serum albumin or
keyhole limpet lemocyani) were less than 0.05 ng per ml. As the
levels of cytokine production by puri®ed CD4+ T cells were not
much different from those obtained by bulk-cultured splenocytes
(data not shown), in later experiments we used the bulk splenic cells
cultured under the above-mentioned conditions as Th1 or Th2
cells.
These cells, suspended in 30 or 50 ml of PBS with OVA (5 mg
per site), were injected into the right ear lobes of naõÈve, non-tg
BALB/C mice to induce Th1- or Th2-induced in¯ammation. The
time course of ear swelling measured at several time points after
injection was different between Th1- and Th2-induced in¯amma-
tion as shown in Fig 2. The ear thickness in the Th1-injected mice
started to increase at 12 h and reached a peak at 48 h after injection,
whereas that in the Th2-injected mice was detectable at 6 h and
became maximal at 24 h in every experiment (Fig 2). We also
carried out a dose±response study to determine the optimal number
of T cells to induce the ear swelling. The intensity of the response
with either Th1 or Th2 was dependent on the number of cells
injected, whereas the overall time course remained unchanged (data
not shown). As the ear swelling induced by either type of T cells
reached a plateau approximately when 1 3 106 cells per site were
injected, we chose 1 3 106 cells for subcutaneous injection in the
later experiments.
In the next experiment, we investigated the histologic differ-
ences between Th1- and Th2-induced swollen ears. In H&E
specimens, untreated ear pinnae showed little in¯ammatory cell
in®ltration (Fig 3a). Only mild cell in®ltration was detected in the
specimen obtained with injection of OVA alone (data not shown).
With injected Th1 or Th2 cells in the presence of OVA, marked
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cell in®ltration and edematous changes were found at either
injected site (Fig 3b, c). The in¯ammatory cells were composed of
mononuclear cells and polymorphonuclear leukocytes. It was hard
to differentiate eosinophils from neutrophils in these H&E
specimens, however. We also used May±GruÈnwald±Giemsa stain-
ing, which enabled us to easily discriminate eosinophils from
neutrophils. The May±GruÈnwald±Giemsa specimens showed that a
vast majority of the polymorphonuclear leukocytes were neutro-
phils and that eosinophils were absent in the Th1-injected swelling
(Fig 3d). In sharp contrast, Th2 cells induced in¯ammation
characterized by a considerable number of eosinophils in addition
to neutrophils (Fig 3e).
Quantitative analysis of Th-induced granulocyte in®ltration
in the air-pouch model produced in the mid-back of naõÈve
mice As mentioned above, we could histologically demonstrate a
distinct pattern of granulocyte in®ltration induced by protein-
antigen-activated Th1 or Th2 cells. In the next experiment, to
more quantitatively analyze the granulocyte accumulation, we
produced air-pouches in the mid-back of naõÈve, non-tg BALB/C
mice as described in Materials and Methods, and then adoptively
transferred Th1 or Th2 cells together with OVA into the pouches.
At indicated time points after injection, the in®ltrated cells were
recovered and counted for the total cell numbers. With smear
samples of these cells on slide glasses stained with May±GruÈnwald±
Giemsa, we further counted the differential leukocyte numbers to
analyze in®ltrating cells. A kinetic study showed that the numbers
of total in®ltrating cells reached a peak at time points corresponding
to those when ear thickness after injection with each type of Th
cells became maximal, as shown in Fig 2. The in®ltrating cells
induced 48 h after injection of Th1 cells were mainly composed of
neutrophils with a small number of eosinophils (Fig 4a). 60%±80%
of in®ltrating cells noted at 48 h were found at 24 h, although
differential leukocyte numbers were similar (data not shown). On
the other hand, Th2 induced an in®ltration consisting of a
considerable number of eosinophils at 24 h after injection (Fig 4b).
The cell numbers were slightly reduced at 48 h.
Systemic or topical FK506 effectively reduced the ear
swelling and granulocyte in®ltration regardless of whether
they were induced by Th1 or Th2 cells Using our ear
swelling and air-pouch models, we evaluated the effects of systemic
administration and topical application of a well-known
immunosuppressant, FK506, which inhibits T cell function
through its action on calcineurin (Schreiber and Crabtree, 1992),
on the ear swelling and granulocyte accumulation induced by Th
cells. Single intraperitoneal administration of FK506 reduced the
ear swelling induced by Th1 or Th2 cells in a dose-dependent
manner (Fig 5a, b). Systemic FK506 also reduced the in®ltration of
both neutrophils and eosinophils into the air-pouch induced by
Th1 or Th2 cells (Fig 5c, d). We further noted that a single topical
application of 0.1% FK506 ointment resulted in a marked reduction
in the ear swelling induced by these T cells (Fig 6).
Administration of drugs capable of inhibiting granulocyte
in®ltration ameliorated ear swelling and the granulocyte
in®ltration induced by Th1 or Th2 cells Next, we evaluated
the effects of two drugs that have a speci®c in¯uence on
granulocyte in®ltration: ONO-6818 speci®cally inhibits
neutrophil elastase, whereas ONO-1078 is a leukotriene receptor
antagonist that inhibits allergen-induced airway eosinophilic
in¯ammation. Single intraperitoneal administration of ONO-
6818 caused a dose-dependent reduction in the ear swelling
induced by Th1 cells, whereas it exerted little effect on that
induced by Th2 cells (Fig 7a). In contrast, ONO-1078 inhibited
ear swelling induced by Th2 cells, but not that by Th1 cells
(Fig 7b). Similar observations were made in experiments with the
air-pouch: the Th1-induced accumulation of neutrophils in the air-
pouch was inhibited by ONO-6818 but not by ONO-1078
(Fig 7c), whereas Th2-induced eosinophilia was inhibited
signi®cantly by ONO-1078 but not signi®cantly by ONO-6818
(Fig 7d). We further carried out in vitro experiments to examine
the effects of these two drugs on the lymphokine production by
OVA-stimulated Th cells. Neither drug affected the production of
respective lymphokines by the antigen-stimulated Th1 or Th2 cells
Figure 1. The lymphokine pro®le produced by Th1 and Th2 cells
prepared by short-term cultures of OVA-speci®c naõÈve T cells.
Th1 and Th2 cells were prepared by a short-term culture of splenic cells
obtained from naõÈve anti-OVA tg mice in the presence of cytokines
required for Th commitment as indicated in Materials and Methods.
Partially puri®ed CD4+ cells were incubated for 48 h with OVA (100
mg per ml) and mitomycin-C-treated spleen cells at a cell density of
2 3 105 per well as antigen-presenting cells. The culture supernatants
were assayed for IFN-g and IL-4 by ELISA methods (see Materials and
Methods). Cytokine secretions from Th1 or Th2 cells without OVA
stimulation or with irrelevant antigens were less than 0.05 ng per ml.
Figure 2. Subcutaneous injection of OVA-speci®c Th1 and Th2
cells with OVA induced ear swelling with different time courses.
Th1 and Th2 cells (1 3 106 cells per site) were adoptively transferred
into the right ear lobes of naõÈve BALB/C mice in the presence (+) or
absence (±) of OVA to produce Th1- and Th2-induced in¯ammation,
respectively. Th1 cells induced delayed type ear swelling that peaked at
48 h, whereas injection of Th2 resulted in ear swelling that peaked
earlier at 24 h. The ear thickness was measured with a precision caliper
immediately before and at various time periods after injection (see
Materials and Methods). Ear swelling was expressed as (thickness of the
right ear after injection ± thickness of the left ear) ± (thickness of the
right ear before the injection ± thickness of the left ear) 3 0.01 mm.
Results are shown as the mean swelling 6 SD.
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(Fig 8). Taken together, ONO-6818, a neutrophil-speci®c elastase
inhibitor, and ONO-1078, a leukotriene receptor antagonist,
speci®cally inhibited Th1-induced neutrophilic and Th2-induced
eosinophilic in¯ammation, respectively, through their direct effects
on granulocytes, but not by their indirect effects via Th cells.
DISCUSSION
In this study, we succeeded in producing allergic skin in¯ammation
by subcutaneous injection of Th1 and Th2 cells prepared from anti-
OVA TCR tg mice with OVA into the skin of naõÈve mice. The
results showed that Th2-mediated ear swelling reached a peak at
24 h after the injection of Th2 cells with OVA, whereas Th1-
mediated ear swelling peaked at 48 h. Histologically, a massive
neutrophil in®ltration was found in the Th1-induced in¯amma-
tion. By contrast we could observe a signi®cantly higher number of
eosinophils mixed with neutrophils in the Th2-induced in¯am-
mation. For quantitative analysis, we produced air-pouches in the
mid-back of naõÈve BALB/C mice. Then, Th cells were adoptively
transferred into the pouch with OVA. Similar to the results of the
histology of swollen ears, we found that Th1 caused a massive
in®ltration of neutrophils and a few eosinophils into the air-pouch,
whereas Th2 induced the accumulation of a much larger number of
eosinophils mixed with neutrophils.
Since the discovery of the Th1 and Th2 cytokine pattern among
CD4+ T cells, many studies have focused on the elucidation of the
signi®cance of these cytokine patterns in immunologic responses.
Th1 and Th2 cytokines normally regulate different types of
immune responses. DTH or contact hypersensitivity is often
associated with Th1 rather than Th2 responses (Cher and
Mosmann, 1987; Fong and Mosmann, 1989; Hauser, 1990;
MuÈller et al, 1993). In fact the cytokines, e.g., IL-2 and IFN-g,
can be detected locally in DTH sites (Murray et al, 1992;
Tsicopoulos et al, 1992) or in lymph nodes draining the DTH
site (Heinzel et al, 1989). Furthermore, resting Th1 clones can
induce footpad DTH in naõÈve mice when locally transferred with
corresponding antigens, and the DTH reaction is partially regulated
by IFN-g (Cher and Mosmann, 1987; Fong and Mosmann, 1989).
Thus, in animal studies, Th1-like cells have been demonstrated to
be responsible for in¯ammatory reactions such as DTH and contact
sensitivity.
By contrast, it has been controversial whether Th2 cells can
really induce such immune-mediated in¯ammatory changes.
Whereas Cher and Mosmann described that Th2 clones were
inactive in a DTH assay (Cher and Mosmann, 1987), there are
certain conditions in which Th2 cells or their cytokines are
involved in the in¯ammatory responses. For example, MuÈller et al
demonstrated that preactivated bulk-cultured Th2 cells and
alloreactive Th2 clones induced footpad in¯ammatory responses
(MuÈller et al, 1993). In addition, the notion that IL-4 is involved in
the development of speci®c in¯ammation is supported by the
observation that IL-4-tg mice developed allergic-like blepharitis
(in¯ammation of the eyelid) (Tepper et al, 1990). These results
suggest that Th2 cells also have the potential to induce DTH-like
in¯ammatory reactions.
In humans, antigen-speci®c Th1 cells can readily be isolated
from the sites of DTH responses observed in diseases (Del Prete et
al, 1994) and skin test sites induced by puri®ed protein derivative
(Del Prete et al, 1991; Haanen et al, 1991). Moreover, there is also
accumulating evidence that Th2 cells can induce in¯ammatory
responses. Th2-like cells were cloned from in¯ammatory skin
lesions of AD (Wierenga et al, 1990; Van der Heijden et al, 1991)
and also identi®ed in late phase skin reactions or in bronchial lavage
specimens recovered from patients with allergic asthma (Kay et al,
1991; Robinson et al, 1992).
Figure 3. Ear swelling induced by Th1 or
Th2 cells corresponded to the intensity of
in®ltration composed of neutrophils or
eosinophils admixed with lymphoid cells.
Th1 and Th2 cell suspensions were injected into
the right ear lobes of naõÈve BALB/C mice with
OVA and animals were sacri®ced 48 h and 24 h
after injection, respectively. The ear lobes were
®xed in 10% formalin and stained with H&E (a,
b, c) or with May±GruÈnwald±Giemsa (d, e). (a)
Only a few lymphoid cells were found in control
ear lobes. (b), (c) Many polymorphonuclear
leukocytes as well as lymphoid cells were found in
the swollen ear lobes injected with 1 3 106 cells
of either Th1 (b) or Th2 (c). (d) Most of the
polymorphonuclear leukocytes were neutrophils in
the May±GruÈnwald±Giemsa-stained section of
Th1-injected ear swelling. (e) In Th2-induced
in¯ammation, we could ®nd many eosinophils
with eosinophilic cytoplasm as well as neutrophils,
although eosinophils were not discriminated from
neutrophils in the H&E section (b).
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Th1 cells and their cytokines are believed to play an important
role in DTH reactions. Among these cytokines, IFN-g is a potent
activator for both macrophages and neutrophils, which are the
major effector cells in DTH reactions. It has been controversial,
however, whether eosinophils are effector cells in Th2-mediated
in¯ammatory responses. In an IgE-independent animal asthma
model, antigen-speci®c Th2 cells can induce eosinophil in®ltration
(Li et al, 1998), although nonspeci®c neutrophil in¯ux was
observed during the early time period in the same model. In
contrast, neutrophil in®ltration was found to predominate in Th2-
induced DTH-like footpad in¯ammatory responses (MuÈller et al,
1995a) when evaluated with H&E-stained histologic sections. As it
was hard to differentiate eosinophils from neutrophils in the H&E-
stained histologic sections, in this study the histologic materials
were stained with May±GruÈnwald±Giemsa. The results indicated
that there were a larger number of eosinophils in the Th2-induced
Figure 4. Th-induced granulocyte in®ltration in air-pouches
produced in the mid-back of naõÈve mice. In order to quantitatively
analyze the granulocyte accumulation, we developed air-pouches on the
mid-back of naõÈve, non-tg BALB/C mice as described in Materials and
Methods, and then adoptively transferred 2 ml of Th1 or Th2 cell
suspension (1 3 106 cells per ml) into the pouches with OVA. At 48 h
(for Th1) or 24 h (for Th2) after the injection, the in®ltrating cells were
recovered and the smear samples of these cells on the slide glasses were
stained with May±GruÈnwald±Giemsa. (a) Th1 cells induced an
in®ltration of neutrophils and a few eosinophils. (b) Th2 induced an
in®ltration of higher numbers of eosinophils.
Figure 5. Systemic FK506 effectively reduced ear swelling and
granulocyte in®ltration by either Th1 or Th2 cells. We evaluated
the effects of single intraperitoneal administration of FK506 on ear
swelling and granulocyte accumulation in the air-pouch. In each
experiment, Th cells were injected in the presence or absence of OVA
antigen as indicated. Intraperitoneal administration of FK506 reduced ear
swelling in a dose-dependent fashion (a, b). The systemic FK506 also
markedly reduced the amount of granulocyte in®ltration induced by Th1
or Th2 cells (c, d). Statistical signi®cance was calculated using Student's t
test: *p < 0.05, **p < 0.001.
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swollen ears and in the in¯ammatory in®ltrates of the air-pouch
model.
Although the mechanism for Th2-mediated in¯ammation is not
fully understood, it is known that IL-4 exerts dual effects on the
in¯ammatory responses. Its negative effects include inhibition of
the upregulation of ICAM-1 and ELAM-1 on endothelial cells
(Thornhill et al, 1991) and suppression of the thrombomodulin
anticoagulation pathway (Kapiotis et al, 1991). In synergy with IL-
1, tumor necrosis factor (TNF), or IFN-g, however, IL-4 enhances
the expression of VCAM-1 on endothelial cells both in vitro
(Masinovsky et al, 1990) and in vivo (Briscoe et al, 1992), and this
was correlated with the increased adhesion and in®ltration of T
cells and eosinophils (Schleimer et al, 1992). These ®ndings suggest
that IL-4 can play either a positive or a negative role during
in¯ammation, depending on other environmental factors. MuÈller et
al (1995b) reported that IL-4 and TNF-a are important regulators
for Th2-mediated footpad DTH.
In this study we also assessed the effects of therapeutic drugs used
for atopic diseases with both the ear swelling and air-pouch models.
We ®rst showed that systemic and topical FK506 reduced the ear
swelling and in®ltrations of both neutrophils and eosinophils into
air-pouches induced by either Th1 or Th2 cells. In the literature,
FK506 is known to exert its effect through the inhibition of
cytokine or chemokine production by Th cells (Schreiber and
Crabtree, 1992; Sasakawa et al, 2000). It still remains to be
elucidated how FK506 in¯uences granulocyte function and
accumulation. As for eosinophils, although there is a report
indicating that FK506 reduces IL-8 expression in human
eosinophils (Kohyama et al, 1999), it was not observed to affect
recruitment of eosinophils or delay worm expulsion in a murine
Figure 6. Topical application of FK506 induced a signi®cant
reduction in ear swelling. Th1 or Th2 cells (1 3 106 cells per site)
were adoptively transferred into the right ear lobes of naõÈve BALB/C
mice with OVA to produce Th1- or Th2-induced in¯ammation. 0.1%
FK506 ointment was applied once topically on the right ear lobes
immediately after injection. Topical application of FK506 resulted in a
marked reduction of ear swelling induced by either type of Th cells. The
ear thickness was measured with a precision caliper, immediately before
and at various time points after injections (see Materials and Methods). Ear
swelling was expressed as (thickness of the right ear after injection ±
thickness of the left ear) ± (thickness of the right ear before the injection
± thickness of the left ear) 3 0.01 mm. Results are shown as the mean
swelling 6 SD. Statistical signi®cance was calculated using Student's t
test: *p < 0.05, **p < 0.001.
Figure 7. Single systemic administration of drugs that are
capable of inhibiting granulocyte in®ltration suppressed the
relevant ear swelling and granulocyte in®ltration into the air-
pouch induced by Th1 or Th2 cells. (a) A single intraperitoneal
administration of a neutrophil-speci®c elastase inhibitor, ONO-6818,
caused a dose-dependent reduction of ear swelling induced by Th1 cells,
although it had a minor effect at a higher dose. (b) In contrast,
intraperitoneal administration of a leukotriene receptor antagonist,
ONO-1078, had inhibitory effects on Th2-induced ear swelling but did
not affect Th1-induced ear swelling. (c), (d) ONO-6818 also suppressed
more effectively the neutrophil accumulation into the air-pouch induced
by Th1 cells than the eosinophil accumulation induced by Th2. ONO-
1078 reduced the eosinophil in®ltration into the air-pouch, but its effects
on the neutrophil in®ltration by Th1 was less effective than ONO-6818.
Statistical signi®cance was calculated using Student's t test: *p < 0.05,
**p < 0.001.
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parasite-infected model (Fujino et al, 1998). As for neutrophils, it
has been reported that FK506 inhibits motility of neutrophils
(Hendey et al, 1992; Burnett et al, 1994) and their degranulation
and production of destructive superoxide radicals (Forrest et al,
1991; Burnett et al, 1994); a recent report indicates that FK506 has
no direct suppressive effect on neutrophil chemotaxis induced by
several chemotactic factors (Sasakawa et al, 2000). Taken together,
we assume that suppression of Th-induced in¯ammatory skin
responses by FK506 is mediated via its effects on granulocytes as
well as on Th cells, although it was not conclusive from the results
of this study.
Interestingly, administration of a neutrophil-speci®c elastase
inhibitor, ONO-6818, caused a reduction in the Th1-induced skin
in¯ammation, but less effectively reduced the Th2-induced one.
On the other hand, a leukotriene receptor antagonist, ONO-1078,
speci®cally inhibited the Th2-mediated ear swelling and eosinophil
in®ltration, whereas it had little effect on the Th1-mediated ones.
We also con®rmed that granulocytes are the therapeutic target cells
of these two drugs, as neither drug affected in vitro production of
IFN-g or IL-4 by antigen-stimulated Th cells. These results suggest
that neutrophils or eosinophils are the major effector cells in Th1-
or Th2-mediated cutaneous in¯ammation.
In conclusion, we demonstrated the usefulness of two unique
murine models to evaluate the contribution of Th1 and Th2 cells to
the development of skin allergic in¯ammation. Using these models
we con®rmed the usefulness of not only well-known but also
potential therapeutic drugs for the treatment of AD and other
atopic diseases. The drugs studied could reduce the relevant
cutaneous in¯ammation and granulocyte in®ltration induced by
protein-antigen-stimulated Th cells.
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